Camson Bio Technologies has filed an application with the Karnataka High Court as part of the process to demerge its seeds business into a different entity.
The company has already received the observation letter from the SEBI and the BSE in this regard.
The shareholding pattern of Camson Seeds, the new demerged entity, will reflect the shareholding pattern of CBTL, said the company in a statement.
Existing investors of the company will get one equity share of Camson Seeds for every share held in Camson Biotech.
The final approval from High Court will see the formal launch of a separate business entity.
Santosh Nair, CEO, Camson, said the process is part of Camson’s efforts to unlock and improve shareholder value.
"The demerger is designed to ensure improved focus to the rapidly growing agri-biotech business while providing shareholders direct participation in the seeds business," he said.